Allspring Global Investments
FATE icon

Allspring Global Investments’s Fate Therapeutics FATE Stock Holding History

Allspring Global Investments’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,362
Closed -$16.3K – 2336
2023
Q4 		$16.3K Buy
+4,362
New +$10.3K ﹤0.01% 1981
2023
Q3 		– Sell
-3,322
Closed -$15.8K – 2819
2023
Q2 		$15.8K Buy
3,322
+1,709
+106% +$9.43K ﹤0.01% 2492
2023
Q1 		$9.19K Sell
1,613
-38,447
-96% -$232K ﹤0.01% 2602
2022
Q4 		$404K Sell
40,060
-208,559
-84% -$3.92M ﹤0.01% 1657
2022
Q3 		$5.57M Buy
248,619
+30,317
+14% +$876K 0.01% 949
2022
Q2 		$5.41M Sell
218,302
-22,025
-9% -$608K 0.01% 965
2022
Q1 		$9.32M Sell
240,327
-3,520
-1% -$136K 0.01% 904
2021
Q4 		$14.3M Buy
+243,847
New +$13.8M 0.02% 815

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return